Puca, Loredana <br/><br/>
Patient derived organoids to model rare prostate cancer phenotypes.  [electronic resource] 

 -  Nature communications  06 2018 
 - 2404 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>2041-1723 
<br/><br/><label>Standard No.: </label>10.1038/s41467-018-04495-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Epigenomics--methods<br/>Gene Expression Profiling--methods<br/>Genomics--methods<br/>Humans<br/>Male<br/>Mice, Inbred NOD<br/>Mice, Knockout<br/>Mice, SCID<br/>Neuroendocrine Tumors--drug therapy<br/>Organoids--metabolism<br/>Phenotype<br/>Prostate--metabolism<br/>Prostatic Neoplasms--drug therapy<br/>Xenograft Model Antitumor Assays